National mining normalization, agents choose products to do five changes!

Three batches of four rounds of national procurement of 112 varieties, saving the health insurance fund more than 50 billion yuan.
, the fourth batch of national tenders will be launched and tenders will be opened on February 3.
the situation of the normalization of national collection and diversification of local collection, how can agent products be reconstructed? 01 Slow disease to "slow disease and specialty" the first batch of "4 plus 7" urban drugs centralized procurement of a total of 25 varieties, blood pressure, blood lipids, blood sugar, cardiovascular and other chronic drugs have 9, accounting for 36%, including blood lipid drug Atovava Statin calcium tablets, rhysovastatin calcium tablets, antihyptophan drug Ebersatan tablets, benzodiamin chloride tablets, Ebersatan hydrochlorin tablets, reinopri tablets, chloratetan potassium tablets, Malay acid innapri tablets 6 varieties.
the second batch of 32 varieties of chronic disease drugs have a capo sugar and other 7 varieties, accounting for 21%.
third batch of national harvest 55 varieties have Viglitin, metformin, pyrithyl tan, pivastatin and other 8 varieties.
three batches of national medicine almost the commonly used slow-disease drugs a net.
of chronic disease medication is large, a variety of national annual sales of less than 1 billion yuan, more than billions of yuan.
after winning the bid, and health insurance direct settlement, there is no intermediate link, agents how to do? First of all, agents should recognize the situation, the general trend of national policy, cheer up the spirit, quickly adjust the product structure.
, play the advantages of doing slow disease products, quickly look for similar products.
first imitation products continue to emerge, such as Viglitin band volume, Viglitin metformin compound preparations have no band, Sigletin metformin, Liglitatin metformin first imitation have come out.
of statins with blood lipids, the first imitation of the folded wheat cloth tablets also came out.
as long as the manufacturer's products, you can maintain the original team.
third, the transition to specialized medication.
such as pediatric products, obstetrics and gynecology products, five official products, orthopaedic products, etc. , the sales of specialized products are not large amount of slow disease medication, relatively easy to enter the hospital, with less risk.
do a few more products, the same can reach the original slow disease products sales.
products, the stronger the anti-risk ability, would rather 10 products annual sales of 100 million yuan, rather than a product annual sales of 100 million yuan.
02 needles to "needles and oral drugs" the first three batches of national harvest, needle varieties are not many.
The first batch of "4 plus 7" city centralized procurement catalog has 3 needle varieties, peme cursordi sodium, fluorobilofen esters, right metomide;
three batches of national harvest a total of only 7 varieties, for the hospital drug share of the largest needle market, only a drop in the Bohai Sea, the share is very small.
but the fourth batch of volume procurement volume catalog 44 varieties 90 product rules, needles have 8 varieties 18 product rules, compared to the first three batches of product regulations greatly increased.
, on May 14, the State Drug Administration issued a document requesting all chemical injection generics to carry out a consistent evaluation of quality and efficacy.
all needle products are required to be evaluated, meaning that in the future needle products will enter the collection.
The author learned that more than three production enterprises have 456 needle products, once all of these 456 products have been evaluated, will inevitably constitute full competition, in line with the conditions of collection, the high probability will be all collected.
, the agent who does the needle product is not long.
agents who make needle products are big men who make medicine.
because of the large sales of needle products, such as antibiotics, cardiovascular needles, neuro-internal and external needles, anti-tumor needles and so on.
variety in the sanjia hospital annual sales of more than 10 million yuan of varieties many.
, agents who do needles are generally reluctant to do oral drugs, because relative to needles, oral medicine is difficult, it is difficult to make large.
, but with the national harvest, regional alliance collection, provincial collection forward, needles have been pushed to the forefront of the wind.
agents to quickly adjust the product structure, from specialized needle products to "needles and oral drugs" transformation.
on the basis of stabilizing the sales of existing needle products, quickly look for oral products, optimize the product structure.
03 Chemical drugs to "chemical drugs and Chinese medicine" agents mostly like chemical drugs, which is determined by the market, chemical drug sales, it is relatively easy to enter the hospital, hospitals are also more favored.
chinese medicine sales are relatively small, difficult to enter the hospital, long cycle, hospital prosecutors generally control Chinese medicine first.
but the first three batches of 112 varieties are all chemical drugs, there will be more chemical drugs into the national collection in the future.
chinese medicine, although there are shortcomings, but also has its advantages.
chinese medicine exclusive varieties long life cycle, a variety to do 10 or even 20 years is normal, long flow of fine water, lasting.
to do chemical agents, these years collection and collection losses, less varieties of agents are even more so.
face of the normalization of the collection, the original specialized in chemical drugs or chemical-based agents, must quickly adjust the product structure, to the "chemical drugs and traditional Chinese medicine" transformation.
choose their own good department, the original do orthopaedic medication, can choose some Chinese medicine orthopaedic varieties, the original do cardiovascular and cerebrovascular disease medication, you can choose some Chinese medicine cardiovascular varieties.
the same, the department unchanged, even if do Chinese medicine, the amount is relatively fast, because doctors, experts are familiar with.
The author believes that the ideal product structure of successful agents must be the combination of length (long-term varieties and short-term varieties), combination of Chinese and Western (Chinese and Western medicine), combination of needle oral medicine.
04 consumables to "supplies and drugs" countries in addition to the implementation of drug collection, equipment collection also sounded the horn.
October 16th, the Joint Procurement Office of High-Value Medical Supplies of National Organizations officially issued the "National Organization Crown Bracket Centralized Belt Purchase Document".
November 5, the first high-value national organization of high-value medical supplies belt procurement opened in Tianjin, as the first product to promote the management of high-value medical supplies reform, the crown vein bracket bid price plummeted, from the average price of about 13,000 yuan to about 700 yuan, according to the amount of intention to purchase, expected to save 10.9 billion yuan in health care costs.
high-value medical supplies such as stents, steel plates, steel nails, hemostable powder, dressings and other hospital consumption.
the "zero rate" of drugs, consumables became the main source of income for hospitals.
large amount of supplies, expensive, high profits, favored by agents.
the relationship between agents who use high-value consumables and hospital deans is so strong that drug dealers can't match them.
these years to do supplies agents earn a pot full.
crown vein bracket collection opened the high-value consumables national collection of the first.
medical steel plate, steel nails, hemostage powder, etc. will follow closely, consumables national collection will also become the norm.
the product structure of such dealers be re-laid? A shift to "consumables and medicines".
do high-value supplies agents generally do not see drugs, think that drugs are too cheap, just like eating abalone ginseng, eating small dishes is not used to the same.
but now the situation has changed, if the product structure is not optimized, the future may not only abalone ginseng did not have to eat, or even small dishes did not have to eat.
agents should give full play to the advantages of contacts in the hospital, quickly import some of the same department of drugs, so that the product structure is more reasonable.
, clinical department is the same, but supplies in the equipment department, drugs in the pharmacy department, the vice president may be different.
but with the support of the clinical department and the first-in-command, these problems will be solved.
05 Health insurance to "medicare plus self-expense" products, whether drugs or supplies, the vast majority of agents are in love with health insurance products, because health insurance products are relatively easy to enter the hospital, sales are larger.
, but with the normal collection of drugs, consumables, medical insurance charges more and more stringent, medical insurance products will be more and more difficult to do.
, agents should adjust the product structure in a timely manner, from health insurance products to "health insurance plus out-of-the-way" products.
-funded products by patients to pay for, do not occupy the health insurance fund, collection risk is small, price autonomy is greater.
do with out-of-your-own products? One is to officially enter the hospital.
will be entered through a pharmacy or device, as prescribed by a clinician.
-funded products do not occupy the share of health insurance, most hospitals are more acceptable.
at the same time, self-pricing products, hospitals also have a certain profit margin.
second is to enter the pharmacy near the hospital.
the patient is prescribed by the doctor, and the patient usually available to the pharmacy to get the medicine (or consumables).
model is now more common.
third is the DTP pharmacy.
DTP pharmacies are booming and thriving.
difference between DTP pharmacies and general pharmacies is: First, whether to seek three-way cooperation, whether the service is upgraded.
second, whether to integrate the market, whether to follow the policy.
third, whether to refine management, whether the execution sinks.
is the upgrade of services, innovation, integration is the integration of markets, policies, sinking is the management of the implementation of the sinking.
three complement each other and rely on each other to create a new type of main-body pharmaceutical service platform.
fourth is the third terminal.
third terminal has become an important terminal channel for many enterprises to compete for, the market potential is huge, self-funded drugs in the third terminal has great potential.
for agents, the national collection is a Nirvana, how to adjust the product structure, adapt to national policy, is a serious problem facing the present.
the right thing to choose, the fittest to survive.
only phoenix bath fire, can Nirvana be reborn.